ArticleCell reports2016

Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling.

Elizabeth Allen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.